Draft NICE guidance recommends innovative technology used to establish whether breast cancer has spread

NICE

17 May 2022 - A magnetic marker liquid injected into people with invasive breast cancer will help surgeons discover if the cancer has spread, after the technology was recommended in draft NICE guidance.

Surgeons working in hospitals with limited or no access to a radiopharmacy department could now use Magtrace and Sentimag as an option to locate sentinel lymph nodes in people with breast cancer.

Read NICE press release

Michael Wonder

Posted by:

Michael Wonder